CD39 (extracellular) Blocking Peptide (#BLP-NT065) is the original antigen used for immunization during Anti-CD39 (extracellular) Antibody (#ANT-065) generation. The blocking peptide binds and ‘blocks’ Anti-CD39 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of mouse brain membranes:
- Western blot analysis of human Jurkat T-cell leukemia cell line (lanes 1 and 3) and human THP-1 monocytic leukemia cell line (lanes 2 and 4) lysates:
- Western blot analysis of mouse BV-2 microglia cell line (lanes 1 and 3) and human HMC3 microglia cell line (lanes 2 and 4) lysates:
- (C)KTSYAGVKEKYLSE, corresponding to amino acid residues 398-411 of human CD39 (Accession P49961).